SCHEMBL613222

SCHEMBL613222

COc1ccc2c(c1OC)CC[C@@H]1CC(=O)NC[C@@H]21

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 1/20 0.46
PDE4A P27815 10/20 0.41
PDE4B Q07343 4/20 0.41
PDE4C Q08493 4/20 0.41
PDE4D Q08499 4/20 0.41
ADRA1A P35348 1/20 0.41
ADRA1B P35368 1/20 0.41
ACHE P22303 1/20 0.40
POLB P06746 1/20 0.40
KDM4E B2RXH2 3/20 0.40
ALDH1A1 P00352 2/20 0.40
HPGD P15428 1/20 0.40
KMT2A Q03164 2/20 0.39
MEN1 O00255 1/20 0.39
CYP3A4 P08684 2/20 0.38
VEGFA P15692 1/20 0.38
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38
LMNA P02545 1/20 0.38
CYP1A2 P05177 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL613221 1.00 PARP1 (0.46) PARP1PDE4APDE4BPDE4CPDE4D
SCHEMBL612709 1.00 PARP1 (0.46) PARP1PDE4APDE4BPDE4CPDE4D
SCHEMBL612710 1.00 PARP1 (0.46) PARP1PDE4APDE4BPDE4CPDE4D
SCHEMBL10504998 0.80 PARP1 (0.42) PARP1ADRA1AADRA1BACHEPOLB
Hydrochloric Acid SCHEMBL10835963 0.79 PARP1 (0.41) PARP1ADRA1AADRA1BKDM4EALDH1A1
Hydrochloric Acid SCHEMBL10835960 0.79 PARP1 (0.41) PARP1ADRA1AADRA1BKDM4EALDH1A1
Hydrochloric Acid SCHEMBL10505302 0.79 PARP1 (0.41) PARP1ADRA1AADRA1BKDM4EALDH1A1
SCHEMBL10835939 0.77 PARP1 (0.45) PARP1PDE4APDE4BPDE4CPDE4D
Hydrochloric Acid SCHEMBL613223 0.77 PARP1 (0.40) PARP1ADRA1AADRA1BKDM4EALDH1A1
Hydrochloric Acid SCHEMBL613843 0.77 PARP1 (0.40) PARP1ADRA1AADRA1BKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9359303-B2 Octahydrobenzoisoquinoline modulators of dopamine receptors and uses therefor PURDUE RESEARCH FOUNDATION (US) 2016-06-07 US disclosed
EP-2421862-B1 OCTAHYDROBENZOISOQUINOLINE MODULATORS OF DOPAMINE RECEPTORS AND USES THEREFOR PURDUE RESEARCH FOUNDATION (US) 2014-06-11 EP disclosed
US-20120041018-A1 OCTAHYDROBENZOISOQUINOLINE MODULATORS OF DOPAMINE RECEPTORS AND USES THEREFOR PURDUE RESEARCH FOUNDATION (US) 2012-02-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120041018-A1 OCTAHYDROBENZOISOQUINOLINE MODULATORS OF DOPAMINE RECEPTORS AND USES THEREFOR DBH, SLC6A3, SLC18A2 PARP1 3119/4885PDE4A 285/4885PDE4B 280/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.